UNCY

Unicycive Therapeutics, Inc.

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Gupta Shalabh K.Director, Officer: CEO
--762.2k shares
Grant / ExerciseMay 14, 2026
Disclosure amount unavailable762.2k shares
--
$7.02
Gupta Shalabh K.Director, CEO
--762.2k shares
Grant / ExerciseMay 14, 2026
Disclosure amount unavailable762.2k shares
--
$7.02
Kenkare-Mitra SaraDirector
--42.1k shares
Grant / ExerciseMay 14, 2026
Disclosure amount unavailable42.1k shares
--
$7.02
Kenkare-Mitra SaraDirector
--84.2k shares
Grant / ExerciseMay 14, 2026
Disclosure amount unavailable84.2k shares
--
$7.02
Kenkare-Mitra SaraDirector
--84.2k shares
Grant / ExerciseMay 14, 2026
Disclosure amount unavailable84.2k shares
--
$7.02
Kenkare-Mitra SaraDirector
--42.1k shares
Grant / ExerciseMay 14, 2026
Disclosure amount unavailable42.1k shares
--
$7.02

News

seekingalpha.comUnicycive Therapeutics: A Catalyst Play With Real Fundamental Upsideseekingalpha.comMay 21globenewswire.comUnicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updateglobenewswire.comMay 12seekingalpha.comUnicycive Therapeutics, Inc. (UNCY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcriptseekingalpha.comApr 16prnewswire.comKuehn Law Encourages Investors of Unicycive Therapeutics, Inc. to Contact Law Firmprnewswire.comApr 9globenewswire.comUnicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conferenceglobenewswire.comApr 9